Benjamin J. Zeskind - Net Worth and Insider Trading

Benjamin J. Zeskind Net Worth

The estimated net worth of Benjamin J. Zeskind is at least $5 Million dollars as of 2024-05-11. Benjamin J. Zeskind is the PRESIDENT AND CEO, 10% Owner of Immuneering Corp and owns about 3,176,779 shares of Immuneering Corp (IMRX) stock worth over $5 Million. Details can be seen in Benjamin J. Zeskind's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benjamin J. Zeskind has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).

Transaction Summary of Benjamin J. Zeskind

To

Benjamin J. Zeskind Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benjamin J. Zeskind owns 1 companies in total, including Immuneering Corp (IMRX) .

Click here to see the complete history of Benjamin J. Zeskind’s form 4 insider trades.

Insider Ownership Summary of Benjamin J. Zeskind

Ticker Comapny Transaction Date Type of Owner
IMRX Immuneering Corp 2024-03-19 director & 10 percent owner & President and CEO

Benjamin J. Zeskind Latest Holdings Summary

Benjamin J. Zeskind currently owns a total of 1 stock. Benjamin J. Zeskind owns 3,176,779 shares of Immuneering Corp (IMRX) as of March 19, 2024, with a value of $5 Million.

Latest Holdings of Benjamin J. Zeskind

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMRX Immuneering Corp 2024-03-19 3,176,779 1.45 4,606,330

Holding Weightings of Benjamin J. Zeskind


Benjamin J. Zeskind Form 4 Trading Tracker

According to the SEC Form 4 filings, Benjamin J. Zeskind has made a total of 4 transactions in Immuneering Corp (IMRX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 20,000 shares on March 19, 2024, which cost Benjamin J. Zeskind around $55,400.

Insider Trading History of Benjamin J. Zeskind

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benjamin J. Zeskind Trading Performance

GuruFocus tracks the stock performance after each of Benjamin J. Zeskind's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Benjamin J. Zeskind is 3.66%. GuruFocus also compares Benjamin J. Zeskind's trading performance to market benchmark return within the same time period. The performance of stocks bought by Benjamin J. Zeskind within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Benjamin J. Zeskind's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Benjamin J. Zeskind

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.69
Relative Return to S&P 500(%) 0.32

Benjamin J. Zeskind Ownership Network

Ownership Network List of Benjamin J. Zeskind

No Data

Ownership Network Relation of Benjamin J. Zeskind


Benjamin J. Zeskind Owned Company Details

What does Immuneering Corp do?

Who are the key executives at Immuneering Corp?

Benjamin J. Zeskind is the director & 10 percent owner & President and CEO of Immuneering Corp. Other key executives at Immuneering Corp include 10 percent owner Cormorant Asset Management, Lp , Vice President & Finance Mallory Morales , and Chief Business Officer Harold Eugene Brakewood .

Immuneering Corp (IMRX) Insider Trades Summary

Over the past 18 months, Benjamin J. Zeskind made 1 insider transaction in Immuneering Corp (IMRX) with a net purchase of 20,000. Other recent insider transactions involving Immuneering Corp (IMRX) include a net sale of 1,309,091 shares made by Cormorant Asset Management, Lp , a net purchase of 100,000 shares made by Peter Feinberg , and a net purchase of 57,965 shares made by Ann E Berman .

In summary, during the past 3 months, insiders sold 1,309,091 shares of Immuneering Corp (IMRX) in total and bought 197,083 shares, with a net sale of 1,112,008 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.

Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immuneering Corp Insider Transactions

No Available Data

Benjamin J. Zeskind Mailing Address

Above is the net worth, insider trading, and ownership report for Benjamin J. Zeskind. You might contact Benjamin J. Zeskind via mailing address: C/o Immuneering Corporation, 245 Main Street, Second Floor, Cambridge Ma 02142.

Discussions on Benjamin J. Zeskind

No discussions yet.